Detalhe da pesquisa
1.
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events.
J Natl Compr Canc Netw
; : 1-8, 2024 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38190801
2.
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center.
Cancers (Basel)
; 16(2)2024 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38254858
3.
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.
Clin Cancer Res
; 27(18): 5062-5071, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34266889